Cell Signaling Technology

Product Pathways - Motif Antibodies

Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb #4391

Applications Reactivity Source Isotype
W IP IHC-P F E-P All Rabbit IgG

Applications Key:  W=Western Blotting  IP=Immunoprecipitation  IHC-P=Immunohistochemistry (Paraffin)  F=Flow Cytometry  E-P=ELISA (Peptide)
Reactivity Key: All=All species expected

Specificity / Sensitivity

Phospho-MAPK Substrates (PXT*P) (46G11) Rabbit mAb detects phospho-threonine in a PXT*P motif. The antibody is phospho-specific, and does not react with phospho-serine- or phospho-tyrosine-containing peptides/proteins. (U.S. Patent No's.: 6,441,140; 6,982,318; 7,259,022; 7,344,714; U.S.S.N. 11,484,485; and all foreign equivalents.)

Source / Purification

Monoclonal antibody is produced by immunizing rabbits with synthetic phospho-MAPK/CDK substrate peptides (KLH-coupled).

Western Blotting

Western Blotting

Western blot analysis of extracts from serum-starved A431 cells, phosphorylated in vitro with MAPK or treated in culture with EGF, using Phospho-MAPK Substrate (PXTP) (46G11) Rabbit mAb. Lysis buffer: 1.0% Triton X-100 (lanes 1 and 2), 2.0% SDS (lanes 3 and 4).

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb.


Flow Cytometry

Flow Cytometry

Flow cytometric analysis of Jurkat cells, U0126-treated (blue) or TPA-treated (green), using Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb compared to a nonspecific negative control antibody (red). Parallel samples were tested without (A) or with (B) lambda phosphatase treatment prior to staining.

ELISA-Peptide

ELISA-Peptide

Phospho-MAPK Substrate (PXTP) (46G11) Rabbit mAb DELFIA® Assay: Signal-to-noise ratio of phospho- versus nonphospho-peptides. T* denotes phosphorylated threonine. (DELFIA® is a registered trademark of PerkinElmer, Inc.)

Background

The MAPK and CDK families of serine/threonine protein kinases play important roles in proliferation and cell cycle control. These kinases phosphorylate threonine or serine followed by a proline residue (1-3). MAPK phosphorylates substrates with the concensus sequence PX(S/T)P, and CDKs phosphorylate substrates containing the concensus sequence (S/T)PXK/R. CST has developed antibodies that bind to phospho-threonine followed by proline, motifs PXS*/T*P and/or S*PXK/R, for use in the study and discovery of new MAPK and CDK substrates (4,5).

  1. Cross, T.G. et al. (2000) Exp Cell Res 256, 34-41.
  2. Reynolds, C.H. et al. (2000) J Neurochem 74, 1587-95.
  3. Seger, R. and Krebs, E.G. (1995) FASEB J 9, 726-35.
  4. Holmes, J.K. and Solomon, M.J. (1996) J Biol Chem 271, 25240-6.
  5. Songyang, Z. et al. (1996) Mol Cell Biol 16, 6486-93.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Rabbit Monoclonals Produced Using Technology from Epitomics, Inc. Under U.S. patent No. 5,675,063.License/Use Restrictions: Use of CST Motif Antibodies within certain methods (e.g., U.S. Patent No.'s 7,198,896 & 7,300,753) may require a license from CST. For information regarding academic licensing terms please have your technology transfer office contact CST Legal Department at CST_ip@cellsignal.com. For information regarding commerical licensing terms please contact CST Business Development at cbunker@cellsignal.com.

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes